Navigation Links
Gene expression profile helps predict chemotherapy response in ovarian cancer patients

A newly identified gene expression profile could help predict how patients with advanced ovarian cancer will respond to chemotherapy treatment. Described in a study in the November 1, 2005 issue of The Journal of Clinical Oncology (JCO), the new findings further establish an important role for microarray gene profiling as a predictor of clinical outcome in ovarian cancer, and could eventually provide clinicians with insights into the mechanisms of drug resistance.

"In many patients with advanced ovarian cancer, post-operative treatment with first-line chemotherapy will result in an excellent clinical response," says senior author Stephen A. Cannistra, MD, director of gynecologic oncology at Beth Israel Deaconess Medical Center (BIDMC) and professor of medicine at Harvard Medical School.

"However," he adds, "due to the lingering presence of chemotherapy-resistant cancer cells, most patients will unfortunately experience a relapse. The goal of our current research is to help determine which patients will relapse and which will not, and to better understand the reasons for this."

Cannistra's group has been working to develop a genetic profile of ovarian cancer that will enable clinicians to more accurately determine a patient's prognosis. As a first step in this process, he and his colleagues last year identified a gene expression profile known as the Ovarian Cancer Prognostic Profile (OCPP), which is predictive of survival in patients with advanced ovarian cancer. (These study results appear in the December 2004 issue of the JCO.)

Their work makes use of a DNA technology known as microarray analysis, in which genes expressed by cancer cells are labeled and applied to a glass slide containing embedded sequences of thousands of known human genes. The genes that are present in the tumor cell bind to their counterpart sequences on the slide and can then be identified through computer analysis.

In this new study, the authors conduct
'"/>

Source:Beth Israel Deaconess Medical Center


Page: 1 2 3

Related biology news :

1. Alcohols effects on gene expression in the central nervous system
2. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
3. Towards precise classification of cancers based on robust gene functional expression profiles
4. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
5. Study: homemade gene expression technology unreliable
6. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
7. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
8. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
9. Computational verification of protein-protein interactions by orthologous co-expression
10. Random gene expression may drive HIV into hiding
11. Confirmation of human protein interaction data by human expression data

Post Your Comments:
(Date:11/25/2009)...OLLA, CAWhen you eat may be just as vital to your ...alk Institute for Biological Studies. Their experi...aning of thousands of genes in the liverthe body,s...od intake and not by the body,s circadian clock as... determines the activity of a large number of gene...
(Date:11/24/2009)...pus Research Institute (LRI) today named 12 new gr... million, recognize innovative work across a broad... their creativity, novelty, and potential to drive..., and cure the complex disease of systemic lupus. ... lupus researchers across the nation and include i...
(Date:11/24/2009)...ists have crystallised a protein that may help gut...protein could be used by probiotic producers to id...it to people. , "Probiotics need to interact with... and if they attach to surfaces in the gut they ar... their activity," says Dr Nathalie Juge from the I...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Global health funding soars boosted by unprecedented private giving 49438 1Global health funding soars boosted by unprecedented private giving 49438 2Global health funding soars boosted by unprecedented private giving 49438 3KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 1KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 2KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 3KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 4KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 5Traumatic brain injury caused by exposure to explosive blast presents critical challenge 49434 1Traumatic brain injury caused by exposure to explosive blast presents critical challenge 49434 2
...ique based on the same technology used to detect c...loyed by scientists at The University of Mancheste...Dr Paul Thomas and a team of researchers are using...irports, to develop a new way of diagnosing lung d...ionex Corporation, is being used to develop a new ...
...ery that could greatly accelerate the search for g...ry Duke University research team has found that th...el for testing human genes implicated in heart dis...id, because the entire genome of the fruit fly is ...rs to systemically screen genes to identify potent...
...es of debate, a U of T researcher has finally dete...low crests had nothing to do with what many scient...n about their function has led to theories that th...rs to snorkels for underwater feeding. Now, David ...of Toronto at Mississauga, has been able to use a ...
Other Biology News:Chemical warfare agent detection technology used to treat lung disease 2Fruit fly's beating heart helps identify human heart disease genes 2Fruit fly's beating heart helps identify human heart disease genes 3
(Date:11/24/2009)..., , REYKJAVIK, Iceland, Nov..., Inc. (Nasdaq: DCGN ) today announced that it has... trading in the company,s common stock will be,sus...ill be filed with the,Securities and Exchange Comm...om listing on Nasdaq, unless the company files an ...
(Date:11/24/2009)..., , SAN MATEO, Calif., Nov. 24 /PRNewswi... a biopharmaceutical company focused on developing...es, announced today that Anthony DiTonno, Presiden...sent at the 21st Annual Piper Jaffray Health Care ...ew York Palace Hotel in New York, New York. ,,...
(Date:11/24/2009)..., , TSX VENTURE: HTL , TORONTO, Nov. 2...SX-V: HTL), formerly Calotto Capital Inc., a leadi...nts for the stem cell research and fertility clini...l results for the third quarter ended September 30...e was $1.46 million compared with $1.43 million in...
(Date:11/24/2009)... Program Connects Customers...mples Collected with DNA Genotek Products , ... 2009 -- DNA Genotek , a leading provider of prod...on and preparation, today announced its new global...nhancements for DNA Genotek,s partner community an...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...nc.,(Nasdaq: RDYN ) today announced its financial...d December 31, 2007., Replidyne reported a net lo...ecember 31, 2007, or a net loss per basic and dilu... net loss of $9.6 million, or $0.36 per,basic and ...er 31, 2006.,For the year ended December 31, 2007,...
...ical and Vaccine Immunology, ANN ARBOR, Mich., Fe...niversity of Michigan have demonstrated their nasa... against 77 times the,potentially lethal dose of s...accines for smallpox. Vaccinia virus is related to...The new vaccine confers a high level of safety bec...
...ertified Partner Provides Framework, for Next Gene... Solutions, ORLANDO, Fla., Feb. 26 Netsmart Tech...ide software and services for health and,human ser...ed Microsoft,Gold Certified Partner status in the ...de at the 2008 Annual Healthcare Information and,M...
Other Biology Technology:Replidyne Announces 2007 Fourth Quarter and Full Year Results 2Replidyne Announces 2007 Fourth Quarter and Full Year Results 3Replidyne Announces 2007 Fourth Quarter and Full Year Results 4Replidyne Announces 2007 Fourth Quarter and Full Year Results 5Replidyne Announces 2007 Fourth Quarter and Full Year Results 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 7Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 2Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 3Netsmart Technologies Announces Development Program on Microsoft for Local Public Health Clinic Management and Vital Records Software 2Netsmart Technologies Announces Development Program on Microsoft for Local Public Health Clinic Management and Vital Records Software 3
Rabbit Anti-CSNK2A1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
UV LAMP 254 NM 8 WATT from GE Healthcare, formerly Amersham Biosciences
... SelectFX Alexa Fluor 488 Cytochrome c Apoptosis D... detect cytochrome c in fixed cells. The kit emplo...lexa Fluor 488 dye-labeled secondary antibody. Ale...e that is compatible with filters and instrument s...
Mouse Anti-NEUROFILAMENTS 140+160 KD Monoclonal Antibody, Unconjugated, Clone BIO-46H from AbD Serotec
Biology Products: